ABOUT US
The award winning Lung Flute is a technology innovation by a group affiliated with former Caltech & NASA associates, the State University of New York at Buffalo, and VA Hospitals, School of Medicine who focused on developing and commercializing acoustic sound wave technology for medical health & preventive consumer products. It has received much recognition and numerous awards.
Awards
- Frost & Sullivan: “Excellence in Technology”
- Popular Science: “A Best Innovation of the Year”
- MD+DI: “Top 50 Companies to Watch”
- Advanced Respiratory Care & Sleep Medicine, Tech Watch
- Frost & Sullivan: “Entrepreneurial Company of the Year, Pulmonary Devices”
- WHO Medical Device Compendium of Innovative Health Technologies for Low-Resource Settings
Intellectual properties
Patents:
- USA – US 6,702.769B1 and 6,984,214 B2
- Japan – 4925293
- China – ZL02828441.0
- India – 225002
- Canada – 2,523,391
- European Union – 23805747
Trademarks:
The Lung Flute holds Trademarks in the following countries and regions:
- United States
- Japan (Katakana)
- Madrid Protocol
- European Union
- China
- India
- Mexico
Completed studies and trials
- Sponsored US VETERAN (VA) HOSPITALS
– Northern Illinois University acoustic bench test
– UB/VA diagnostic clinical trial
– UB/VA therapeutic COPD clinical trial
– UB/VA therapeutic COPD clinical trial – long term 6-month study (Published Clinical and
Translational Medicine)
- Third Party Sponsored
– Perceptronix/St. Paul’s Lung Cancer diagnostic trial
– Japanese TB diagnostic clinical trial
– Australia – Sydney Children’s Hospital –Sputum induction in CF
– University of Maryland – “Evaluation of Lung Flute in Sputum Samples for the
Analysis of Lung Cancer”
– Philippines numerous therapeutic and diagnostic trials completed.
- Buffalo, NY – UB/Buffalo General Medical Center
– (NYSTAR Grant) PI Stanley Schwartz MD PhD, Division Chief – “Impact of Lung Flute® Therapy on Asthma”
– End points of ACT, PFT, FeNO
– https://clinicaltrials.gov/ct2/show/NCT02003521
- Tokyo, Japan – multi-site
– Sputum induction for TB diagnosis. 500 patients.
- Sydney, Australia – Concord Hospital
– Lung Flute® vs. Flutter randomized comparison trial in bronchiectasis. 168 patients. End points of sputum collection and weight
– Belgium – Doctors at Institute of Tropical Medicine started to conduct LF ECO efficacy clinical study. They organized the collaboration with Japanese RIT to test LF ECO for TB active case finding. Conclusion: The LF ECO Disposable can contribute to eliminating TB death from the Planet Earth.